| Name: | Description: | Size: | Format: | |
|---|---|---|---|---|
| 651.64 KB | Adobe PDF |
Advisor(s)
Abstract(s)
Background: Clostridium difficile infection (CDI) is the leading cause of healthcare-associated diarrhea, and several
outbreaks with increased severity and mortality have been reported. In this study we report a C. difficile PCR
ribotype 027 outbreak in Portugal, aiming to contribute to a better knowledge of the epidemiology of this agent in
Europe.
Methods: Outbreak report with retrospective study of medical records and active surveillance data of all inpatients
with the diagnosis of CDI, from 1st January to 31th December 2012, in a Portuguese hospital. C. difficile isolates were
characterized regarding ribotype, toxin genes and moxifloxin resistance. Outbreak control measures were taken,
concerning communication, education, reinforcement of infection control measures, optimization of diagnosis and
treatment of CDI, and antibiotic stewardship.
Results: Fifty-three inpatients met the case definition of C. difficile-associated infection: 55% males, median age was
78.0 years (interquartile range: 71.0-86.0), 75% had co-morbidities, only 15% had a nonfatal condition, 68% had at
least one criteria of severe disease at diagnosis, 89% received prior antibiotherapy, 79% of episodes were nosocomial.
CDI rate peak was 13.89/10,000 bed days. Crude mortality rate at 6 months was 64.2% while CDI attributable cause
was 11.3%. Worse outcome was related to older age (P = 0.022), severity criteria at diagnosis (leukocytosis (P = 0.008)
and renal failure), and presence of fatal underlying condition (P = 0.025). PCR ribotype 027 was identified in 16 of 22
studied samples.
Conclusions: This is the first report of a 027-CDI outbreak in Portugal. We emphasize the relevance of the measures
taken to control the outbreak and highlight the importance of implementing a close and active surveillance of CDI.
Description
Keywords
Clostridium Difficile Hospital Outbreak Ribotype 027 Portugal Infecções Gastrointestinais
Pedagogical Context
Citation
BMC Infect Dis. 2014 Apr 17;14:209. doi: 10.1186/1471-2334-14-209
Publisher
BioMed Central
